TRACK RECORD & MILESTONES 2010 Feb Health Vision Enterprise appoints Rogers Luo as National Sales Director 2009 Dec Health Vision’s targeted products have all been successfully listed in China’s National Drug Reimbursement List 2009 Oct Management buyout of Stada’s 51% share of Health Vision Enterprise Ltd to re gain 100% control 2008 July Appointed Eisai China Inc. as the marketing agent for Alpha Lipon®, a company with a focus in endocrinology 2007 Oct Full launch of FibinGluRAAS® with the set up of a specialist team Health Vision (Nan Jing) Medicine Company Limited obtains GSP license 2007 Apr Obtain business license for Health Vision (Nan Jing) Medicine company, a wholly foreign owned enterprise allowing importation, logistic distribution and licensing-in products 2007 Mar Obtain exclusive marketing agreement with Shanghai RAAS for their innovative haemostatic product, FibinGluRAAS®, a dual syringe containing fibrinogen and thrombin 2005 May Stada acquires operations of Beijing Center-Lab Pharmaceuticals Ltd. to strengthen operation in China 2005 Jan Launched the most powerful oxidative stress inhibitor – Alpha-Lipon® (alpha lipoic acid) for the treatment of diabetic neuropathy 2004 Sept Azelastine nasal spray listed on the State Drug List for reimbursement 2004 July Launched the fastest acting treatment for allergic rhinitis – Azep® (azelastine HCl) Nasal Spray 2001 Merged with STADA to become Health Vision Enterprise (HVE) Ltd Established Health Vision Consulting (Shanghai) Ltd, a wholly foreign owned enterprise 2000 Added Gelomyrtol® Forte children's strength to the portfolio 1999 Gelomyrtol® Forte listed in the top 200 pharmaceutical producs (IMS) 1997 Launched Gelomyrtol® Forte for the treatment of sinusitis and bronchitis 1996 Entered China with the establishment of Representative offices in Beijing, Shanghai and Guangzhou. Launched Nitro lingual Spray® 1995 Health Vision (HK) Ltd – founded by Zona Yim and Alex Leung in Hong Kong. << Click here for more >>